Market Trends of Blister Packaging Industry
This section covers the major market trends shaping the Blister Packaging Market according to our research experts:
Pharmaceutical Industry Account for a Major Share
- The pharmaceutical sector poses a different set of demands for the blister packaging solutions regarding insulation from external surroundings, high levels of protection, cost-effectiveness, and ease of handling, in addition to retaining the medicine's effectiveness.
- These packs are uniquely suited to meet the stringent standards and highly valued for protective properties, adaptability, cost-effectiveness, and the pharmaceutical and packaging industry requirements.
- When drugs are packaged in blisters, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
- The retail-level preparation of prescription drugs is troubling pharmacists or pharmaceutical technicians. The administration of medicines in the open atmosphere of the supermarket and drug store can negatively affect sensitive drugs when they are transferred from container to container. Blister packaging can ensure the process of distribution directly to the customer.
- Protecting product integrity remains the primary goal of pharmaceutical packaging, but as in all areas of the packaging industry, there is continued work on cost reduction in the packaging process.
- According to healthcare informatics, diabetes expenditure was USD 42 billion in 2013 and increased to USD 78 billion in 2018. Moreover, blister-packed medicines can prove to be very helpful in the transportation of medicines, such as those used for diabetes, which may be transported over long distances.
Europe to Hold a Significant Share
- The pharmaceutical and healthcare industry holds the dominant share of the blister packaging market in Europe. The consumer goods sector is also expected to contribute a significant market share over the forecast period. Blister packaging also provides the possibility to create a compliance pack or calendar pack by labeling the prescription, to which patients can easily adhere.
- The European community has more substantial environmental incentives to use blister packaging because of the stringent regulations overusing the excess material into the packaging system. The use of blister packaging allows manufacturers to reduce packages to a minimal size. In Europe, the UK pharmaceutical industry is one of the major engines of innovation and research. The industry spends billions on R&D and employs vast numbers of highly skilled personnel for R&D roles.
- These massive investments and the proportion of skilled workers employed show how Britain is building up the pipeline of medicines and future drugs. These ongoing investments can be perceived as an excellent opportunity for the growth of blister packaging in the country.